Zobrazeno 1 - 10
of 90
pro vyhledávání: '"W. Littlejohn"'
Autor:
Kathy Domenici, Stephen W. Littlejohn
'By'granting the other specificity,'authors Domenici and Littlejohn successfully uphold the important values of human dignity, honor, and respect as anchoring points in which the story of the book evolves.'—Stella Ting-Toomey, California State Univ
Autor:
Stephen W. Littlejohn, Kathy Domenici
Written from the authors′ experience in conflict intervention in their private consulting practice, Engaging Communication in Conflict uses a communication perspective to address insights and methods in private mediation, small group facilitation,
Autor:
Kristen L. Cole, Stephen W. Littlejohn
Publikováno v:
Review of Communication. 18:352-369
Moral conflict theory explains deep moral differences and patterns of communication commonly associated with such conflicts. Moral conflict is defined as a struggle between humans, but we argue tha...
Autor:
Kathy Domenici, Stephen W. Littlejohn
Publikováno v:
The Blackwell Handbook of Mediation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9f4f51817b3aa815dcb7eab2e3dfbdb8
https://doi.org/10.1002/9781405164238.ch10
https://doi.org/10.1002/9781405164238.ch10
Autor:
Thomas W. Littlejohn, Maureen Kobe, Naitee Ting, Joel M. Neutel, George L. Bakris, Ludwin Ley, Arya M. Sharma
Publikováno v:
Clinical Therapeutics. 34:537-551
Hypertensive patients with diabetes often require combination therapy to achieve a blood pressure (BP) goal, and evidence suggests that time to BP goal is crucial to decrease cardiovascular risk.The aim of the study was to investigate whether the sin
Autor:
Hayes M. Dansky, Patrice H. Gibbons, Yale B. Mitchel, Thomas W. Littlejohn, James M. McKenney, Sherry Liu, Christine McCrary Sisk, Diane Tribble, Daniel M. Bloomfield
Publikováno v:
American Heart Journal. 162:708-716
This report describes the lipid and safety data collected during an off-drug period that followed 8 weeks of treatment with the cholesteryl ester transfer protein inhibitor, anacetrapib (ANA). A total of 589 patients with primary hypercholesterolemia
Autor:
Brian K. Roberts, Thomas W. Littlejohn, Yun-Jung Choi, David B. Karpf, Ronald M. Krauss, Sue Naim, Boris Kerzner, Wang Xueyan, Harold E. Bays, Sherwyn Schwartz
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 96:2889-2897
Preclinical and clinical studies suggest that peroxisome proliferator-activated receptor (PPAR)-δ agonists favorably affect multiple metabolic parameters that are otherwise proatherogenic, many that are not optimally managed with statins alone.The a
Autor:
Giuseppe Mancia, Willie Oigman, Mary Seeber, Helmut Schumacher, Claudio R. Majul, William B. White, Rafael Olvera, Thomas W. Littlejohn
Publikováno v:
Blood Pressure Monitoring. 15:205-212
Evaluation of combination therapy with antihypertensive agents by clinic blood pressure (BP) measurements may yield results that differ from out-of-office BP readings. This is of clinical relevance because out-of-office BP values are of prognostic im
Publikováno v:
Human Performance. 22:391-409
When providing performance ratings, it is commonly assumed that raters agree more on rating items that are behaviorally based and observable than on items that are vague and less behaviorally based. This study empirically investigated the relationshi
Autor:
Thomas W, Littlejohn, Claudio R, Majul, Rafael, Olvera, Mary, Seeber, Maureen, Kobe, Robert, Guthrie, Wille, Oigman, S, Yates
Publikováno v:
J Clin Hypertens (Greenwich)
This randomized 4×4 factorial study determined the efficacy and safety of telmisartan (T) plus amlodipine (A) in hypertensive patients. Adults (N=1461) with stage 1 or 2 hypertension (baseline blood pressure [BP]: 153.2[12.1]/101.7[4.3] mm Hg) were